We hypothesized that downregulation of miR-335 and-145 in BC cells promoted proliferation, cell cycle, and inhibition of apoptosis through overexpression of PD-L1, mediated via promoter methylation of miR-335 and -145, suggesting that miR-335 and -145 might have potential as novel therapeutic targets for BC. Here, CD274 is linked to breast cancer.